Aldeyra Therapeutics, Inc. (ALDX)
4.125
-0.54
(-11.67%)
USD |
NASDAQ |
Mar 13, 16:00
4.32
+0.20
(+4.73%)
After-Hours: 20:00
Aldeyra Therapeutics Shareholders Equity (Quarterly) : 44.25M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| MediciNova, Inc. | 41.59M |
| Merck & Co., Inc. | 52.61B |
| Altimmune, Inc. | 224.89M |
| Actinium Pharmaceuticals, Inc. | 13.78M |
| Rhythm Pharmaceuticals, Inc. | 139.07M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 72.06M |
| Total Liabilities (Quarterly) | 27.81M |
| Debt to Equity Ratio | 0.351 |
| Current Ratio | 2.544 |
| Net Debt Paydown Yield | 0.01% |